TY  - JOUR 
AU  - Puerto-Camacho, Pilar
AU  - Amaral, Ana Teresa
AU  - Lamhamedi-Cherradi, Salah-Eddine
AU  - Menegaz, Brian A.
AU  - Castillo-Ecija, Helena
AU  - Ordóñez García, José Luis
AU  - Domínguez, Saioa
AU  - Jordan-Perez, Carmen
AU  - Diaz-Martin, Juan
AU  - Romero-Pérez, Laura
AU  - Lopez-Alvarez, Maria
AU  - Civantos-Jubera, Gema
AU  - Robles-Frías, María José
AU  - Biscuola, Michele
AU  - Ferrer, Cristina
AU  - Mora, Jaume
AU  - Cuglievan, Branko
AU  - Schadler, Keri
AU  - Seifert, Oliver
AU  - Kontermann, Roland
AU  - Pfizenmaier, Klaus
AU  - Simón, Laureano
AU  - Fabre, Myriam
AU  - Carcaboso, Ángel M.
AU  - Ludwig, Joseph A.
AU  - de Álava, Enrique
PY  - 2019
SN  - 1078-0432
UR  - http://hdl.handle.net/10366/158869
AB  - [EN] Endoglin (ENG; CD105) is a coreceptor of the TGFb family that is highly expressed in proliferating endothelial cells. Often coopted by cancer cells, ENG can lead to neo-angiogenesis and vasculogenic mimicry in aggressive malignancies. It exists...
LA  - eng
PB  - American Association for Cancer Research
KW  - Endoglin
KW  - Ewing Sarcoma
TI  - Preclinical Efficacy of Endoglin-Targeting Antibody–Drug Conjugates for the Treatment of Ewing Sarcoma
DO  - 10.1158/1078-0432.CCR-18-0936
T2  - Clinical Cancer Research
VL  - 25
M2  - 2228
ER  -